Pradella et al., 2021 - Google Patents
A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosisPradella et al., 2021
View HTML- Document ID
- 7272490786454273100
- Author
- Pradella D
- Deflorian G
- Pezzotta A
- Di Matteo A
- Belloni E
- Campolungo D
- Paradisi A
- Bugatti M
- Vermi W
- Campioni M
- Chiapparino A
- Scietti L
- Forneris F
- Giampietro C
- Volf N
- Rehman M
- Zacchigna S
- Paronetto M
- Pistocchi A
- Eichmann A
- Mehlen P
- Ghigna C
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
Abstract The Netrin-1 receptor UNC5B is an axon guidance regulator that is also expressed in endothelial cells (ECs), where it finely controls developmental and tumor angiogenesis. In the absence of Netrin-1, UNC5B induces apoptosis that is blocked upon Netrin-1 binding …
- 101700030712 UNC5B 0 title abstract description 58
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pradella et al. | A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis | |
Tang et al. | GPR116, an adhesion G-protein–coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway | |
Giampietro et al. | Stathmin expression modulates migratory properties of GN-11 neurons in vitro | |
CA2807918C (en) | New markers for the epithelial and proliferative or mesenchymal invasive phenotype of human neoplasias | |
Xu et al. | Novel regulators of retina neovascularization: a proteomics approach | |
US9034327B2 (en) | G protein coupled receptor protein and use thereof | |
US7745585B2 (en) | Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI) | |
MX2012012735A (en) | Detection and modulation of slit and roundabount (robo) mediated lymph vessel formation and uses thereof. | |
US7648827B2 (en) | Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases | |
US7479369B2 (en) | Use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases | |
Grainger et al. | EGFR confers exquisite specificity of Wnt9a-Fzd9b signaling in hematopoietic stem cell development | |
Moucaud et al. | Amalgam plays a dual role in controlling the number of leg muscle progenitors and regulating their interactions with developing tendon | |
Elmi | The Role and Regulation of Store Operated Calcium Entry (SOCE) in Breast Cancer | |
Mahmoud Kazan | Characterizing the role of endofin/ZFYVE16 in cell surface receptor trafficking and tumor suppression | |
US20190360054A1 (en) | Method for diagnosis of metastatic cancer or taxane-based drug-resistant cancer by using lmcd1 protein and gene coding therefor | |
US20070042981A1 (en) | Use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases | |
KR101099650B1 (en) | Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin ?5 | |
EP2250195B1 (en) | Sulfatase enzymes | |
Babu | Role of MET in SV40-induced mammary tumorigenesis | |
Narayan et al. | Role of MET in SV40-induced mammary tumorigenesis | |
Quantin | MIR-7 targets pax6 and modulates bladder cancer cell migration | |
Bellelli | NCOA4 depletion leads to replication stress and premature senescence | |
To | Y-box binding protein-1 induces MET, CD44, and CD49f thereby promoting the capacity for tumour initiation. | |
Lim | The study of the role of bone morphogenetic proteins in prostate cancer progression | |
JP2006254830A (en) | Material for suppressing sept11 gene expression |